Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect in USD of SYNOPSYS INC from 2017 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Summary
SYNOPSYS INC quarterly/annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect history and change rate from 2017 to Q4 2024.
  • SYNOPSYS INC Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for the quarter ending 31 Jan 2025 was -$241M, a 24.7% increase year-over-year.
  • SYNOPSYS INC annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for 2024 was $2.46B, a 11425% increase from 2023.
  • SYNOPSYS INC annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for 2023 was $21.3M.
  • SYNOPSYS INC annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for 2022 was -$15.3M, a 108% decline from 2021.
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Quarterly (USD)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, YoY Quarterly Change (%)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Annual (USD)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, YoY Annual Change (%)

SYNOPSYS INC Quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 -$241M +$79.1M +24.7% 01 Nov 2024 31 Jan 2025 10-Q 26 Feb 2025
Q4 2023 -$320M -$57.4M -21.9% 01 Nov 2023 31 Jan 2024 10-Q 26 Feb 2025
Q4 2022 -$263M +$46M +14.9% 01 Nov 2022 31 Jan 2023 10-Q 23 Feb 2024
Q4 2021 -$309M -$96M -45.2% 01 Nov 2021 31 Jan 2022 10-Q 17 Feb 2023
Q4 2020 -$213M -$184M -653% 01 Nov 2020 31 Jan 2021 10-Q 18 Feb 2022
Q4 2019 -$28.2M +$103M +78.4% 01 Nov 2019 31 Jan 2020 10-Q 19 Feb 2021
Q4 2018 -$131M +$311M +70.4% 01 Nov 2018 31 Jan 2019 10-Q 21 Feb 2020
Q4 2017 -$442M 01 Nov 2017 31 Jan 2018 10-Q 25 Feb 2019

SYNOPSYS INC Annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $2.46B +$2.44B +11425% 01 Nov 2023 31 Oct 2024 10-K 19 Dec 2024
2023 $21.3M +$36.6M 01 Nov 2022 31 Oct 2023 10-K 19 Dec 2024
2022 -$15.3M -$213M -108% 01 Nov 2021 31 Oct 2022 10-K 19 Dec 2024
2021 $197M -$310M -61.1% 01 Nov 2020 31 Oct 2021 10-K 12 Dec 2023
2020 $507M +$502M +9083% 01 Nov 2019 31 Oct 2020 10-K 12 Dec 2022
2019 $5.53M +$331M 01 Nov 2018 31 Oct 2019 10-K 13 Dec 2021
2018 -$325M -$395M -567% 01 Nov 2017 31 Oct 2018 10-K 15 Dec 2020
2017 $69.7M 01 Nov 2016 31 Oct 2017 10-K 20 Dec 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.